Rothblatt Martine A 的 Form 4 申報
United Therapeutics Corp（UTHR），2025/10/27 申報
- 申報編號
- 0001106578-25-000023
- 申報時間
- 2025/10/27
- 交易日
- 2025/10/23-10/24
- 申報延遲
- 4 天
- 10b5-1 計畫
- 有勾選
這份申報列了 8 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $338.5 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Rothblatt Martine ACIK 0001106578 | 董事、高階主管（董事長、執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/10/23 | Common Stock | M行使選擇權取得 | +4,000 | $120.26 | +$481,040 | 4,130 | 直接 | |
| 2025/10/23 | Common Stock | S賣出處分 | −2,500 | $421.63F2 | −$1,054,075 | 1,630 | 直接 | |
| 2025/10/23 | Common Stock | S賣出處分 | −1,000 | $422.58 | −$422,580 | 630 | 直接 | |
| 2025/10/23 | Common Stock | S賣出處分 | −500 | $424.16 | −$212,080 | 130 | 直接 | |
| 2025/10/24 | Common Stock | M行使選擇權取得 | +4,000 | $120.26 | +$481,040 | 4,130 | 直接 | |
| 2025/10/24 | Common Stock | S賣出處分 | −2,937 | $423.56F3 | −$1,243,995.72 | 1,193 | 直接 | |
| 2025/10/24 | Common Stock | S賣出處分 | −563 | $424.64F4 | −$239,072.32 | 630 | 直接 | |
| 2025/10/24 | Common Stock | S賣出處分 | −500 | $426.40 | −$213,200 | 130 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/10/23 | Common Stock | M行使選擇權處分 | −4,000 | $0.00 | $0 | 158,000 | 直接 | |
| 2025/10/24 | Common Stock | M行使選擇權處分 | −4,000 | $0.00 | $0 | 154,000 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This transaction was executed in multiple trades at prices ranging from $421.37 to $421.995. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F3
This transaction was executed in multiple trades at prices ranging from $423.015 to $424.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $424.19 to $424.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。